This is a preview of subscription content, log in via an institution to check access.
Notes
folinic acid, fluorouracil and oxaliplatin
folinic acid, fluorouracil and irinotecan
2017 US dollars
Reference
Chu JN, et al. Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Cancer : 12 Oct 2018. Available from: URL: http://doi.org/10.1002/cncr.31795
Rights and permissions
About this article
Cite this article
Nivolumab +/- ipilimumab not cost effective for metastatic CRC. PharmacoEcon Outcomes News 815, 22 (2018). https://doi.org/10.1007/s40274-018-5403-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5403-3